| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $128.9M | +1404.0% |
| R&D Expense | $151.5M | -32.6% |
| SG&A Expense | $39.9M | -21.7% |
| Operating Income | -$83.4M | +69.8% |
| Interest Expense | $4.6M | -12.7% |
| Pre-tax Income | -$85.4M | +69.1% |
| Income Tax | -$12K | -180.0% |
| Net Income | -$85.4M | +69.1% |
| EPS (Basic) | -$11.41 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $25.0M | -3.1% |
| Short-term Investments | $17.5M | -32.5% |
| Accounts Receivable | $1.5M | -95.7% |
| Inventory | $10.7M | +9.8% |
| Current Assets | $64.9M | -36.3% |
| Total Assets | $109.1M | -34.1% |
| Current Liabilities | $134.6M | -5.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$68.7M | +64.4% |
| Capital Expenditures | $246K | -79.9% |
| Investing Cash Flow | $8.6M | -93.0% |
| Financing Cash Flow | $59.3M | +2849.4% |
| Free Cash Flow | -$69.0M | +64.5% |
| -337.2% |
| EPS (Diluted) | -$11.41 | -337.2% |
| Total Liabilities |
| $206.4M |
| -22.0% |
| Stockholders' Equity | -$97.3M | +2.0% |